Press "Enter" to skip to content

New patent for NOVO drug FIASP

0
Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug FIASP

Annual Drug Patent Expirations for FIASP
Annual Drug Patent Expirations for FIASP

Fiasp is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug.

FIASP drug price trends.

This drug has twenty-six patent family members in eighteen countries.

The generic ingredient in FIASP is insulin aspart. One supplier is listed for this compound. Additional details are available on the insulin aspart profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug FIASP
    Do NOT follow this link or you will be banned from the site!